CAPPELLO JOSEPH (VP, Pharmaceutical Development) sold 0.4% of their position (605.00 shares) of GENELUX CORP on the open market
Open‑market sale worth $1.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 5/13/2026ACC: 0001493152-26-022568
Officer· VP, Pharmaceutical Development
Since Jan 2023
-605.00
Net shares
Net seller
$1.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
605.00 disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−605.00
Price / share
$2.97
Trade value
$1.80K
% of position
0.4%
5/11/2026
155.15K→154.55K
Total
Net shares
−605.00
Net value
-$1.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/11/2026 | S · Sale | −605.00 | $2.97 | $1.80K | 0.4% | 155.15K | 154.55K |
| Total | −605.00 | -$1.80K | ||||||
Derivative Transactions0
No derivative transactions reported